Ultrasensitive DNA hypermethylation detection using plasma for early detection of NSCLC: a study in Chinese patients with very small nodules

[1]  H. Nielsen,et al.  Genome-wide cell-free DNA fragmentation in patients with cancer , 2019, Nature.

[2]  W. Liang,et al.  Non-invasive diagnosis of early-stage lung cancer using high-throughput targeted DNA methylation sequencing of circulating tumor DNA (ctDNA) , 2019, Theranostics.

[3]  P. Massion,et al.  Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges. , 2019, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[4]  Alexander Y. Trick,et al.  Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study , 2019, Clinical Cancer Research.

[5]  A. Jemal,et al.  Cancer statistics, 2019 , 2019, CA: a cancer journal for clinicians.

[6]  The Lancet Respiratory Medicine Lung cancer screening in Europe: hurdles to overcome. , 2018, The Lancet. Respiratory medicine.

[7]  Y. Dor,et al.  Principles of DNA methylation and their implications for biology and medicine , 2018, The Lancet.

[8]  Charles Swanton,et al.  Early stage NSCLC — challenges to implementing ctDNA-based screening and MRD detection , 2018, Nature Reviews Clinical Oncology.

[9]  Tim De Meyer,et al.  Analysis of DNA methylation in cancer: location revisited , 2018, Nature Reviews Clinical Oncology.

[10]  A. Ruano-Raviña,et al.  Low-dose CT for lung cancer screening. , 2018, The Lancet. Oncology.

[11]  H. D. de Koning,et al.  Clinically detected non-aggressive lung cancers: implications for overdiagnosis and overtreatment in lung cancer screening , 2018, Thorax.

[12]  F. Hirsch,et al.  Early detection of lung cancer by using an autoantibody panel in Chinese population , 2018, Oncoimmunology.

[13]  M. Esteller,et al.  Lung cancer epigenetics: From knowledge to applications. , 2017, Seminars in cancer biology.

[14]  P. Huang,et al.  Added Value of Computer-aided CT Image Features for Early Lung Cancer Diagnosis with Small Pulmonary Nodules: A Matched Case-Control Study. , 2018, Radiology.

[15]  Matthew B Schabath,et al.  Radiologic Features of Small Pulmonary Nodules and Lung Cancer Risk in the National Lung Screening Trial: A Nested Case-Control Study. , 2018, Radiology.

[16]  Wei Zhang,et al.  Genome-wide DNA methylation profiling reveals novel epigenetic signatures in squamous cell lung cancer , 2017, BMC Genomics.

[17]  Lesley Uttley,et al.  The evidence base for circulating tumour DNA blood-based biomarkers for the early detection of cancer: a systematic mapping review , 2017, BMC Cancer.

[18]  Yi-long Wu,et al.  The emerging roles of NGS-based liquid biopsy in non-small cell lung cancer , 2017, Journal of Hematology & Oncology.

[19]  F. Khuri,et al.  Gene Methylation Biomarkers in Sputum and Plasma as Predictors for Lung Cancer Recurrence , 2017, Cancer Prevention Research.

[20]  C. Zahnow,et al.  Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations. , 2017, Cancer cell.

[21]  Sam Angiuoli,et al.  Direct detection of early-stage cancers using circulating tumor DNA , 2017, Science Translational Medicine.

[22]  M. Brock,et al.  Non-blood circulating tumor DNA detection in cancer , 2017, Oncotarget.

[23]  William A. Flavahan,et al.  Epigenetic plasticity and the hallmarks of cancer , 2017, Science.

[24]  F. Khuri,et al.  Gene methylation biomarkers in sputum as a classifier for lung cancer risk , 2017, Oncotarget.

[25]  Frank C. Detterbeck,et al.  The Eighth Edition Lung Cancer Stage Classification , 2017, Chest.

[26]  Y. Rozenholc,et al.  Base-Position Error Rate Analysis of Next-Generation Sequencing Applied to Circulating Tumor DNA in Non-Small Cell Lung Cancer: A Prospective Study , 2016, PLoS medicine.

[27]  J. Herman,et al.  Early Detection of Lung Cancer Using DNA Promoter Hypermethylation in Plasma and Sputum , 2016, Clinical Cancer Research.

[28]  H. Ye,et al.  Circulating Tumor DNA Detection in Early-Stage Non-Small Cell Lung Cancer Patients by Targeted Sequencing , 2016, Scientific Reports.

[29]  Ash A. Alizadeh,et al.  Circulating tumour DNA profiling reveals heterogeneity of EGFR inhibitor resistance mechanisms in lung cancer patients , 2016, Nature Communications.

[30]  A. Uitterlinden,et al.  Genetic and environmental influences interact with age and sex in shaping the human methylome , 2016, Nature Communications.

[31]  A. Jemal,et al.  Cancer statistics in China, 2015 , 2016, CA: a cancer journal for clinicians.

[32]  P. Śliwiński,et al.  Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease , 2015, British Journal of Cancer.

[33]  J. Herman,et al.  Functional Identification of Cancer-Specific Methylation of CDO1, HOXA9, and TAC1 for the Diagnosis of Lung Cancer , 2014, Clinical Cancer Research.

[34]  Ash A. Alizadeh,et al.  An ultrasensitive method for quantitating circulating tumor DNA with broad patient coverage , 2013, Nature Medicine.

[35]  Tza-Huei Wang,et al.  Extraction and processing of circulating DNA from large sample volumes using methylation on beads for the detection of rare epigenetic events. , 2013, Clinica chimica acta; international journal of clinical chemistry.

[36]  K. Pantel,et al.  Circulating tumor cells and circulating tumor DNA. , 2012, Annual review of medicine.

[37]  W. Rom,et al.  Molecular Analysis of Plasma DNA for the Early Detection of Lung Cancer by Quantitative Methylation-Specific PCR , 2010, Clinical Cancer Research.

[38]  Yi Zhang,et al.  Single-tube analysis of DNA methylation with silica superparamagnetic beads. , 2010, Clinical chemistry.

[39]  Steven S. Chang,et al.  Evaluation of Promoter Hypermethylation Detection in Body Fluids as a Screening/Diagnosis Tool for Head and Neck Squamous Cell Carcinoma , 2008, Clinical Cancer Research.

[40]  F. Gilliland,et al.  Gene Promoter Methylation in Plasma and Sputum Increases with Lung Cancer Risk , 2005, Clinical Cancer Research.

[41]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[42]  N. Dubrawsky Cancer statistics , 1989, CA: a cancer journal for clinicians.